dihexa hgf c-met agonist (PNB-0408) | c-Met/HGFR Activator Therapeutic targeting of HGF/c-Met pathway.

The Integrated Regenerative Axis TB-500 (Actin Sequestration): Binds to G-actin to prevent polymerization, facilitating the "sliding" of cells to wound edges and promoting cellular flexibility

Mechanism of Action The BPC-157 + TB-500 Blend has been investigated for the complementary mechanisms of its two components

A dosage of 2ml is recommended as safe, anything more could cause irritation at the injection site

Combined use in experimental designs may help characterize interactions between cytoprotective/vascular and structural-repair pathways

Dihexa binds with high affinity to HGF and both dihexa and its parent compound Norleucine 1-AngIV induce c-Met phosphorylation in the presence of subthreshold concentrations of HGF and augment HGF-dependent cell scattering